Hydroxypropyl methylcellulose (HPMC), also known as hypromellose, is produced through the synthetic alteration of the natural polymer cellulose and is considered safe for human consumption. HPMC is rapidly being used as an alternative to hard shell gelatin capsules, since these natural capsules are manufactured using plant extracts. They meet the dietary and cultural needs of vegetarians by offering excellent alternatives to gelatin capsules. The HPMC material is present in the form of an off-white powder or granules which are hygroscopic and practically insoluble in hot water, acetone, and chloroform, but disintegrate readily in cold water, forming a colloidal solution due to their thermal reversible gelation property. The FDA clinical trials for the safety of HPMC material using rats have exhibited no adverse reaction to this material. It is therefore considered safe for human consumption. Also, the capsules’ in-vitro studies have displayed better performance in terms of dissolution/disintegration and decreased time of development compared to gelatin capsules.
The global hydroxypropyl methylcellulose (HPMC) capsules market is witnessing an unprecedented growth rate. Several clinical trials and research studies are directed toward the HPMC encapsulation of new as well as existing drugs. Gelatin capsules hold a significant share in the pharmaceutical market. The HPMC capsules have significant opportunity of capturing this market space. The drawbacks of gelatin capsules such as water content, along with the significant acceptance of as well as demand from vegetarians for alternatives create excellent opportunities for HPMC capsules to capture this market space. They are also encapsulation machine-friendly, and do not require for them to be re-arranged or modified.
The global hydroxypropyl methylcellulose (HPMC) capsules market has been segmented based on product type into the following divisions: pectin, carrageenan, glycerin, gellan gum, and others. In terms of capsule size, the market is classified into the following segments: 00, 0, 1, 2, 3, and 4. On the basis of route of administration, the global hydroxypropyl methylcellulose (HPMC) capsules market is categorized into the oral, inhalation, vaginal, and rectal categories. Oral HPMC capsules are expected to account for a significant market share due to their ease of administration, significant utilization rates, and effective masking of the taste and odor of the medicines within. By end-use industry, the market is split into the following sections: pharmaceuticals, food, neutraceuticals, dentistry, cosmetics, and others. The utilization rate of HPMC capsules in the pharmaceutical industry is likely to increase rapidly, followed by neutraceuticals. The increasing trend of acquiring established regional manufacturers to carry out independent in-house manufacturing of HPMC capsules in order to reduce the production expenditure with advanced technologies has been observed among major players operating in the global market. However, stability issues related to the capsules for certain drugs may restrain the market.
On the basis of geography, the global hydroxypropyl methylcellulose (HPMC) capsules market has been distributed over five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is predicted to reflect a high CAGR due to the significant vegetarian population, multiple HPMC capsule manufacturers, changing government regulations & guidelines for the human consumption of HPMC capsules, and adoption of better health care facilities. North America is projected to dominate the global hydroxypropyl methylcellulose (HPMC) capsules market owing to factors such as the increasing innovations in technologically advanced products, immense per capita health expenditures, and significant investments in R&D for effective treatment alternatives.
Key players in the global hydroxypropyl methylcellulose (HPMC) capsules market include Capsugel Belgium NV, ACG-Associated Capsules, Catalent, Inc, Qualicaps Co., Ltd., Suheung Capsule Co., Ltd., SUNIL HEALTHCARE LIMITED, Mitsubishi Chemical Holdings Corporation, ACG World, and Encap, among others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.